Coffee Beauty Products Market Size Worth $835.5 Million By 2025

The global coffee beauty products market size is expected to reach USD 835.5 million by 2025, expanding at a CAGR of 5.1% from 2019 to 2025, according to a new report by Grand View Research, Inc. Growing awareness about harmful impacts of synthetic chemicals and prominent inclination towards natural ingredient based beauty solutions has been driving the market. In addition to this, rising awareness about caffeine benefits such as enhanced blood circulation for skin and presence of antioxidant and anti-aging effects is expected to drive the market.

Companies are focusing on manufacturing coffee beauty solutions, thereby catering to consumers who are seeking natural based products. For instance, MCaffeine, India’s first caffeinated personal care brand, offers a wide range of coffee infused products such as face scrubs, body butter, body scrub, and face masks to provide the customers with benefits of coffee ingredients. Mr. Bean Body Care also provides coffee scrub in different flavors such as coconut, coco berry, Manuka honey, peppermint, along with body balms, which help in reducing the appearance of stretch marks, varicose veins, and age spots.

Skin care held the largest share of 34.5% in 2018. People are more concerned about their aging skin, which is driving them to use more of coffee beauty products than others, which, in turn, is expected to contribute to its demand. For instance, Mr Bean Body Care provides coffee mocha mud masks that help in cleansing skin and minimize the pore size, which is grounded with coffee beans, macadamia oil, and kaolin clay.

Hair care is expected to expand at a CAGR of 5.8% over the forecast period. Benefits such as improvement and strengthening of hair texture, enhanced blood circulation in scalp, and prevention from hair loss are some of the factors expected to impact the demand for the segment.

Online mode of distribution is an emerging mode of a channel, expanding at a CAGR of 5.6% over the forecast period. Availability of a wide range of products from premium as well as international brands is also one of the key factors expected to drive the acceptance of online purchase. Moreover, luxury brands such as The Body Shop have their own online channels apart from physical stores to make access easier for the consumers.

Asia Pacific is expected to register a CAGR of 5.8% over the forecast period. Adoption of western culture and inclination towards the trends of European countries for the usage of caffeine in beauty products are driving the market in the region. French brand, Terre De Mars is all set to launch its luxury coffee based face scrub and body scrubs soon for millennials.

Key players in the market include L’Oréal Paris; Avon Product Inc.; Bio care; Mr. Bean Body Care; The Body Shop; Java Skin Care; Estee Lauder Inc.; The Beauty Company; OGX; and MCaffeine. Demand for coffee beauty products that are free from harsh chemicals has been growing over the past few years. Major market players have been significantly contributing into research and development to make more of these products available according to the needs of the consumers.

Various market players are involved in manufacturing a variety of coffee beauty products such as body scrubs, masks, shampoos, perfumes, and lip care. Companies namely Loreal Paris, Java Skin care, and Estee Lauder launch lip glosses, lipsticks, and body and face scrubs made of coffee beauty products.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/coffee-beauty-products-market

Further key findings from the study suggest:

Skin care dominated the global market with a share of 34.5% in 2018
Europe dominated the market in 2018. This trend is projected to continue over the next few years owing to growing demand for hair care products
Asia Pacific is expected to witness high demand over the forecast period due to increasing exposure and demand for coffee beauty products
coffee beauty products market is highly competitive in nature with the main players including Estee Lauder, Body Bean Care, The Body Shop, and L’Oréal Paris
Various manufacturers are concentrating on new product launches and capacity expansion to estimate existing and future demand patterns from upcoming product segments.

U.S. Hotels, Resorts & Cruise Lines Market Worth $299.3 Billion By 2025

The U.S. hotels, resorts & cruise lines market is expected to reach USD 299.3 billion by 2025, according to a new report by Grand View Research, Inc. As travel and tourism keep on growing every year, hotel and cruise line industry are recognized as an ever-blooming business. High competition is observed amongst the companies due to soaring demand for accommodation. This, in turn, is anticipated to boost the revenue inflow in this market.

Currently, majority of the population are tech-savvy and are comfortable using mobile apps and websites. Customers prefer to plan their trips and search for hotel options all via a digital interface. As a result, hotels are engaged in offerings up-to-date and user-friendly services such as online bookings, cancellation, and payment mode. This, in turn, is expected to enable company in reinforcing their presence in the space.

Effective usage of digital marketing & social media promotions is recognized as the high driving force for the market. This is mainly because it allows maintaining harmony and synergy between companies and customers, thereby driving booking rates. Moreover, usage of public forum like Yelp helps in understanding the customer’s’ expectation which further helps in devising the investment plans as per the customer’s need.

However, alternate accommodation such as Airbnb and security challenges associated with this industry is expected to slow down the market throughout the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/us-hotels-resorts-cruise-lines-market

Further Key Findings From the Report Suggest:

Hotel & motel dominated the market in 2016 with respect to revenue generation
Presence of a substantial number of international hotels in the U.S. has contributed to the largest share of this segment
In the crowded tourist or travel spots, it is easy to spot hotels in every locality
Cruise lines is the fastest growing segment
Understanding the growth potential of cruising travel, the cruise line industry is committed to add new capacity in its lines
The cruise lines are continuously putting efforts for improving its “cheap and fun vacation deals”
These factors are expected to lucratively enhance the segment growth throughout the forecast period
Some major hotel companies that are operating in the space are Hyatt Corporation, MARRIOTT INTERNATIONAL, INC.; and Hilton
Royal Caribbean International and Carnival Corporation & plc are some prominent cruise line in the market
These companies are observed to make significant investment to boost their service portfolio and meet the customers’ expectations

Biopharmaceuticals Manufacturing Consumables Testing Market Worth $709.92 Million By 2025

The global biopharmaceuticals manufacturing consumables testing market size is expected to reach USD 709.92 million by 2025 at a 12.1% CAGR, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/biopharmaceuticals-manufacturing-consumables-testing-market

Further key findings from the study suggest:

Based on service, compendial and multi-compendial testing held the largest share owing to demand from various manufacturers for raw materials that are compliant to regulatory standards
Testing services for Active Pharmaceutical Ingredients (APIs) accounted for the largest revenue share owing to the presence of a wide range of services in this segment
Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2017. Rising competitive rivalry amongst market participants is also attributive for the large share of this region
Asia Pacific is expected to emerge as the fastest-growing regional market, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations
Key service providers in the market include Eurofins Scientific; Merck KGaA; Charles River; Agilent Technologies; and Catalent, Inc. These service providers are engaged in contract partnerships with major biopharmaceutical manufacturing companies.

Retinal Implant Market Size Worth $74.7 Million By 2026

The global retinal implant market size is expected to reach USD 74.7 million by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.6% over the forecast period. Increasing prevalence of target diseases, and rising geriatric population are the key driving factors for the market. Rising capability of restoring vision is anticipated to bode well for demand over the forecast period.

Laser therapy and Photodynamic Therapy (PTD) and some of the conventional treatments available for Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD). Drugs such as Lucentis, Macugen, Eylea, and Vitamin A are a part of therapeutic treatment. Such treatments aid in reducing disease progression and thereby, delaying blindness. However, none of these treatments can completely cure the disease and restore vision. As a result, treatment procedures that restore vision are highly in demand.

Currently approved devices are capable of restoring vision with the help of electrodes, camera chips, lenses, software, and other tools. Moreover, implantable miniature telescope, Argus II is easy to use and enables patients to carry out their daily activities with ease. Furthermore, these devices can be used for a prolonged period of time, eliminating the need for another surgery. Therefore, the capability of advanced implantable devices to restore vision is expected to propel the market growth in near future.

Increasing geriatric population and rising disposable income in developing economies such as Japan, China, and India are also expected to boost the retinal implant market over the forecast period. Moreover, increasing healthcare expenditure by governments and private sectors and initiatives by major market players to operate in untapped regions are also anticipated to propel the growth in the forthcoming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/retinal-implant-market

Further key findings from the study suggest:

In terms of revenue, implantable miniature telescope segment is projected to expand at the highest CAGR over the forecast period. Increasing prevalence of AMD among geriatric population and usage of implantable devices to treat vision problems might drive the segment’s growth over the forecast period
In 2026, Asia-Pacific market is expected to witness the fastest CAGR over the forecast period owing to increasing geriatric population and disposable income
VisionCare, Inc.; Retina Implant AG; and Second Sight Medical Products, Inc. are expected to dominate the retinal implant market over the forecast period.

Paper Diagnostics Market Worth $10.50 Billion By 2025

The global paper diagnostics market size is estimated to reach USD 10.50 billion by 2025, according to a new report by Grand View Research, Inc, rising at a CAGR of 8.0% during the forecast period. Increasing prevalence of diseases such as cancer, autoimmune diseases, and inflammatory diseases is one of the key factors expected to fuel the demand for novel and rapid diagnostics techniques, thereby driving the market during the forecast period. For instance, as per the American Cancer Society, in 2018, around 1.7 million new cancer cases are likely to be diagnosed and 609,640 individuals are poised to die due to cancer. The number of cancer cases is projected to rise by around 70.0% over the next two decades. This trend is anticipated to help the market gain momentum during the forecast period.

Rising R&D investments, technological advancements, and new product launches are the key growth strategies incorporated by companies to cater to rising needs. ARKRAY Inc.; Acon Laboratories, Inc.;Abbott; Bio-Rad Laboratories; Siemens healthcare; Abcam Plc; and Abingdon Health are some of the players focusing on new product development by rising R&D investments. For instance, in March 2017, ARKRAY Inc. launched saliva testing system, capable of measuring cariogenic bacteria, acidity & buffer capacity, occult blood, leukocyte & proteins, and ammonia from saliva. Moreover, in May 2017, ACON Laboratories, Inc. received U.S. FDA approval for its “Mission Urine Reagent Strips” for detection of Microalbumin and Creatinine.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/paper-diagnostics-market

Further key findings from the report suggest:

Introduction of technologically advanced paper based diagnostic products, which offer sensitive and rapid results, is estimated to boost market growth over the forecast period
Development of paper-based ELISA for detection of autoimmune antibodies in body fluid is expected to bolster the demand for technologically advanced & upgraded lateral flow assays over the forecast period
Lateral flow assays held a significant share in the market in 2017, owing to wide application in disease diagnostics and associated advantages such as robust & rapid results, sensitivity, ease of use, and cost efficiency
Paper based diagnostic devices are widely used as point-of-care diagnostics. Increasing inclination towards these devices can be attributed to advent of wax patterning technology, facilitating greater flexibility and adaptability
In terms of application, the clinical diagnostics segment is likely to witness lucrative growth during the same period. Rising awareness regarding their benefits such as improved control and rapid results and growth prospects in area of nanomaterial & biomolecules are contributing to the growth of the segment
In 2017, North America was the most prominent regional market, owing to surging demand for self-testing devices coupled with well-established healthcare infrastructure
Market leaders are involved in R&D activities to develop accurate, cost efficient, and sensitive paper based microfluidics. Focus on mergers and acquisitions, consistent system upgradation through R&D investments and fund raising are some of the key strategies adopted by players.

Polyphenylene Oxide Market Worth $2.27 Billion By 2025

The global polyphenylene oxide (PPO) market size is projected to reach USD 2.27 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.3% during the forecast period. Rising demand from end-user industries such as automotive and electronics & electrical. Globally, surging demand for electronic products such as outlet boxes, smoke detectors, and lighting is poised to boost the growth of the PPO market. Improving living standards coupled with increasing per capita disposable income is estimated to positively impact the market over the forecast years. Burgeoning automotive manufacturing in Latin America and Asia Pacific is expected to stimulate the growth of the market.

Rising consumer awareness regarding new technologies in emerging economies is anticipated to fuel the demand for advanced electronic components. Increasing trade of electronic devices among countries is anticipated to unfold immense growth opportunities for market players. Electronic components emerged as the leading application segment in the polyphenylene oxide market. Major products where electronic components are used are relay housings, pump housing/impellers, connectors, bobbins, circuit breakers, motor brush cards, coil encapsulation, fans and blowers, heat exchangers, thermostat housings, and large and small appliances.

Increasing PPO applications in the electrical and electronics industry such as TV output transformer, air conditioning control boxes, deflection yoke, and bobbins are slated to stoke the growth of the market. Asia Pacific is the leading regional market, with a global volume share estimated at over 50.0% in 2017. Favorable economic policies coupled with the entry of global plastic manufacturers are supporting the growth of the market in Asia Pacific. A well-established electrical & electronics manufacturing base in China, Taiwan, and South Korea coupled with a strong chemical manufacturing base in India is likely to trigger the adoption of polyphenylene oxide. China being the major market has witnessed tremendous growth in end-use industries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/polyphenylene-oxide-ppo-market

Further key findings from the report suggest:

In terms of revenue, the automotive application is expected to rise at a CAGR of 4.1% from 2018 to 2025 owing to growing automotive production in emerging economies
The U.S. polyphenylene oxide market is anticipated to exceed 85 kilo tons by 2025, owing to the presence of a large number of automotive companies and rapidly increasing shale gas operations
The PPO market is moderately concentrated owing to the presence of both large as well as small players
Some of the key companies present in the market are BASF, SABIC, Mitsubishi Chemical Holdings Corp., Sumitomo Chemicals, Momentive Performance Materials, LyondellBasell, Polyplastics Co. Ltd., Asahi Kasei Chemicals Corp., and Solvay SA.

Natural Zeolites Market Size Worth $8.01 Billion By 2025

The global natural z eolites market size is expected to reach USD 8.01 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 2.7% over the forecast period. Increasing investments in development of new infrastructure in the global construction industry are expected to propel the product demand. The usage of natural zeolites is prominent in construction materials owing to their hygroscopic qualities and the ability to balance pH. Natural zeolites are pozzolanic materials, which are used to enhance strength of the structure.

The construction industry is witnessing considerable growth not only in emerging economies but also in developed countries such as the U.S. In 2017, construction spending in U.S. was 4.5% higher than in 2016. The growth of global construction industry has led to the increased use of cement. Cement manufacturing is a major contributor to greenhouse gas emissions, and thus, natural zeolites are used in construction materials as a partial replacement for cement.

Soil remediation and water treatment applications are expected to augment growth of the natural zeolites market. Soil contamination is a major concern in the European and Asian countries. According to the European Environment Agency, Europe had approximately 2.5 million potentially contaminated land sites in 2014. Similarly, almost one-fifth of the land in China is rich in cadmium. In 2013, it was reported that rice grown in Hunan province of China was contaminated with cadmium. Also, 44% of rice samples were found to be contaminated with cadmium in Guangzhou. Owing to the increasing soil contamination, materials such as natural zeolites, are being used in soil amendment applications to improve the overall health and quality of soil and the crops.

China has been a major producer and consumer of natural zeolites on a global scale since many years. Their usage is prominent in China owing to an increase in the demand for construction materials and the requirement for soil amendment products. China is the largest cement producer in the world and has been witnessing high use of natural zeolites such as Pozzolan cement.

The growth of the natural zeolites market is affected by presence of substitutes. Both minerals and non-minerals are a threat to the market in major applications including construction materials, water treatment, and soil amendment. For example, activated carbon in water treatment and bentonite clay in soil amendment can hinder demand. Major players in the global market are increasing their production capacities by establishing new plants; joint ventures; and through acquisitions to increase their customer reach in the international markets.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/natural-zeolites-market

Further key findings from the study suggest:

Construction materials is anticipated to remain the largest segment throughout the forecast period, in terms of revenue, on account of benefits such as improved strength and durability of structures obtained due to the use of natural zeolites
The soil remediation segment is anticipated to expand at a CAGR of 3.4% in terms of value over the forecast period due to increasing land contamination
In terms of volume, animal feed accounted for a share of 14.3% in 2017, owing to the increasing animal feed production in North America and South America
Asia Pacific is anticipated to be the leading region in the market throughout the forecast horizon, owing to rapid infrastructural developments
Some of the key companies operating in the natural zeolites market are KMI Zeolite, Zeocem a.s., United States Antimony Corporation, and Zeotech Corporation. They are attempting to increase their consumer base, for instance, in December 2017, Canadian Zeolite Corp. acquired Earth Innovations Inc., which has an established distribution network in Canada.

Carbon Fiber Reinforced Plastic Market Worth $27.98 Billion By 2024

The global carbon fiber reinforced plastic market size is expected to reach USD 27.98 billion by 2024, according to a new report by Grand View Research, Inc. Increasing composites demand in the automotive industry is expected to remain a key driving factor for global CFRP market. Aerospace & defense application segment contributed significantly to shape the overall revenue owing to the high cost of aerospace grade CFRP. Research and development in the aviation industry for manufacturing components capable of withstanding high environmental stresses is anticipated to fuel CFRP market growth over the next eight years.

Extensive R&D activities particularly in Japan and Europe have led to the emergence of numerous market players, which in turn is expected to drive the regional market demand. Escalating CFRP demand in sports applications, specifically in the Asia Pacific region, is anticipated to impel CFRP consumption.

Although CFRP offers excellent benefits due to its superior strength and lesser weight, its expensive nature has restricted its use to certain high performance applications only. Although CFRP offers considerable advantages, high cost associated with the same poses a challenge for the market across various other application segments.

Polyacrylonitrile (PAN) precursor is expected to gain some of the market shares over the forecast period and is projected to account for around 97% of the total demand in 2024. PAN has gained popularity on account of its superior properties over pitch precursor. Lower cost of PAN as compared to pitch-based CFRP is also anticipated to foster the industry growth.

Advantages offered by thermoplastic carbon fiber plastic over thermosetting composites such as short processing time, high impact resistance, easy storage, and recyclability are expected to fuel thermoplastic CFRP demand.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/carbon-fiber-market

Further key findings from the report suggest:

Global carbon fiber reinforced plastic market demand was 92.9 kilo tons in 2015 and is expected to reach 269.5 kilo tons by 2024, growing at a CAGR of 12.5% from 2016 to 2024
The low cost and high strength to weight ratio of PAN-based carbon composites are expected to drive polyacrylonitrile demand for CFRP production over the forecast period
Automotive is expected to be the fastest growing segment of carbon fiber reinforced plastic market with a market share of 19.7% of the total volume in 2015
North America emerged as the most dominant regional market accounted for 36.9% in 2015 of the market volume because of the growing demand in automotive and aviation industry
Most of the key market players such as Cytec Industries, Toray, Zoltek, Toho, Mitsubishi Rayon Corporation, Hexcel, and Hyosung have integrated along the major part of the value chain ranging from production and raw material supply to CFRP distribution. High level of integration enables companies to cut down the cost associated with raw material procurement and strengthens their market share with the development of specialty products.

Automotive Electronic Control Unit Market Worth $84.29 Billion By 2025

The global automotive electronic control unit market size is expected to reach USD 84.29 billion by 2025, growing at a 4.4% CAGR over the forecast period, according to a study conducted by Grand View Rese0arch, Inc. The increasing demand for hybrid and luxury vehicles, rising deployment of infotainment systems, and growing preference for ADAS and automated safety systems are fueling the demand for automotive electronic control units (ECUs). Additionally, a growing number of functionalities to control several electronic components in the vehicle such as, dashboard instruments, engine, telematics, and powertrain, has also resulted in significant growth in the average number of ECUs used per vehicle.

Moreover, the governments and regulatory bodies are mandating the installation of several safety systems in a vehicle, such as adaptive cruise control, adaptive front lighting, and anti-lock braking system, among others, to increase road safety. Recently, the AUTOSAR Alliance has been formed to standardize the approach of the designing and developing of layers between ECU hardware and application software. Additionally, in April 2016, the European New Car Assessment Programme (NCAP) was launched to reduce the risk of accidents by mandating the integration of lane-departure warning and anti-lock braking systems in vehicles during their production phase. This is anticipated to make the integration of hardware and software more scalable and flexible.

Furthermore, the automotive ECU market directly depends upon the automotive production across the globe. Thus, the increasing automotive production across emerging economies would fuel the demand for automotive ECUs over the forecast period. Several government initiatives to mandate the installation of advanced safety systems in vehicles, coupled with the growing preference of consumers for luxury and hybrid vehicles are the key factors boosting the research & development spending on automotive ECUs. For instance, In October 2017, NXP Semiconductors N.V. revealed NXP S32 platform, an all-new control and compute concept for electric, autonomous and connected cars.

The Asia Pacific region dominated the market in 2018, a trend that is expected to continue over the forecast period. This is attributed to the significant investments in the automotive industry in emerging countries, such as China, South Korea, Japan, and India. Additionally, the Chinese market is estimated to reach USD 36.65 billion by 2025, growing at a CAGR of 9.5% from 2019 to 2025. Continuous technological innovations to reduce the ECU count per vehicle is also expected to create substantial opportunities in the Asia Pacific region.

The North American market is projected to expand at a considerable CAGR over the forecast period owing to several regulations and declarations made by the governments in the region to positively influence the demand for electric vehicles. For instance, the Californian government has set up a target of reaching 1.5 million zero-emission vehicles, thus boosting the regional demand.

Some of the key players operating in the market are Altera (Intel Corporation), Autoliv Inc., Continental AG, Delphi Technologies, Denso Corporation, Hyundai Mobis, NXP Semiconductors N.V., Robert Bosch GmbH, Valeo Inc., and ZF Friedrichshafen AG, among others. The global automotive ECU market is consolidated with the presence of a few players holding a majority share of the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-ecu-market

Further key findings from the study suggest:

The ADAS & safety systems application segment is anticipated to dominate the automotive electronic control unit market owing to stringent government regulations and rising consumer awareness pertaining to safety features in vehicles. The segment is estimated to reach USD 27.6 billion by 2025.
The Internal Combustion Engine (ICE) vehicles segment is estimated to hold a majority share of the market owing to the increasing production of vehicles in emerging economies.
The 32-bit segment held the largest market share of 91.0% in 2018. This share is expected to decline over the forecast period due to the rising demand for 64-bit ECUs to integrate advanced electronic functions in the vehicle.
The passenger car segment held the largest market share of 86.9% in 2018. This share is estimated to increase over the forecast period owing to the growing consumer preference for luxury and hybrid vehicles with advanced electronic and safety systems.
The Asia Pacific regional market is estimated to account for 62.8% of the overall automotive ECU industry in 2018, owing to the increasing production of vehicles in emerging economies, such as China, India, South Korea, and so on.
Prominent market players include Autoliv, Inc., Delphi Technologies, Denso Corporation, Robert Bosch GmbH, ZF Friedrichshafen AG.

eClinical Solutions Market Worth $15.7 Billion By 2027

The global eClinical solutions market size is expected to reach USD 15.7 billion by 2027, according to a new report by Grand View Research, Inc., progressing at a CAGR of 13.8% during the forecast period. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.

Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost the market over the forecast period.

Moreover, digital transformation in the field of clinical trials and preference for a data-centric approach is providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.

Adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision making in every stage of the development process. They also help reduce cost and time between development phases by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which is helpful in making quick decisions.

Market players engage in new product development and strategic alliances, including partnership agreements, promotional activities, and acquisitions, to keep market rivalry high. For instance, in October 2017, Oracle entered into a collaboration with Healthx Inc. to provide SaaS solutions to healthcare payers for core administration and digital engagement.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the report suggest:

CTMS led the eClinical solutions market by product in 2019 owing to benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
By delivery mode, cloud-based systems are anticipated to exhibit the highest CAGR during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring
CROs held the largest share in the market in 2019 on the basis of end use. The segment is projected to expand at a remarkable pace during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure
Key players operating in the market include DATATRAK International, Inc.; IBM Watson Health; Medidata Solutions Inc.; Oracle Corporation; BioClinica; PAREXEL International Corporation; CRF Health; OmniComm Systems Inc.; and ERT. Most companies engage in various business strategies such as mergers and acquisitions and new product development to gain greater market share.